Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients

Journal of Clinical Microbiology

Volumn 50, Issue 2, 2012, Pages 465-468

  Descamps, V ^a,b   Op De Beeck, A ^c   Plassart, C ^a,b   Brochot, E ^a,b   Francois C ^a,b   Helle, F ^b   Adler, M ^d   Bourgeois, N ^d   Degre D ^c,d   Duverlie, G ^a,b   Castelain, S ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LIVER BIOPSY; LIVER FIBROSIS; LIVER LEVEL; LIVER PARENCHYMA; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADULT; AGED; BIOPSY; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOASSAY; LIVER; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SERUM; STATISTICS AS TOPIC; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 84856159397     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06503-11     Document Type: Article

References (22)

1. Alsaleh K, et al. 2010. Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity. J. Virol. 84:12515-12528.
2. Bouvier-Alias M, et al. 2002. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 36:211-218. (Pubitemid 34700780)
3. Castelain S, et al. 2004. TaqMan amplification system with an internal positive control for HCV RNA quantitation. J. Clin. Virol. 31:227-234. (Pubitemid 39311803)
4. Chevaliez S. 2011. Virological tools to diagnose and monitor hepatitis C virus infection. Clin. Microbiol. Infect. 17:116-121.
5. Goueslain L, et al. 2010. Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication. J. Virol. 84:773-787.
6. Maillard P, et al. 2001. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J. Virol. 75:8240-8250. (Pubitemid 32743696)
7. Matsuura K, et al. 2009. Abbott RealTime hepatitis C virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV assays for prediction of sustained virological response to pegylated interferon and ribavirin in chronic hepatitis C patients. J. Clin. Microbiol. 47:385-389.
8. Mederacke I, et al. 2009. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. J. Clin. Virol. 46:210-215.
9. Miedouge M, et al. 2010. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J. Clin. Virol. 48:18-21.
10. Morota K, et al. 2009. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. J. Virol. Methods 157:8 -14.
11. Moscato GA, et al. 2011. Quantitative determination of hepatitis C core antigen in therapy monitoring for chronic hepatitis C. Intervirology 54:61-65.
12. Park Y, Lee JH, Kim BS, Kim DY, Han KH, Kim HS. 2010. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J. Clin. Microbiol. 48:2253-2256.
13. Pawlotsky JM, et al. 2000. Standardization of hepatitis C virus RNA quantification. Hepatology 32:654-659.
14. Pawlotsky JM, Chevaliez S, McHutchison JG. 2007. The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology 132:1979-1998. (Pubitemid 46695724)
15. Pyne MT, Konnick EQ, Phansalkar A, Hillyard DR. 2009. Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqManHCVanalyte-specific reagent assay. J. Clin. Microbiol. 47:2872-2878.
16. Romero-Gomez M, et al. 2001. Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption. Dig. Liver Dis. 33:698-702. (Pubitemid 33107671)
17. Ross RS, et al. 2010. Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification. J. Clin. Microbiol. 48:1161-1168.
18. Schuttler CG, et al. 2004. Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera. J. Clin. Microbiol. 42:1977-1981. (Pubitemid 38637810)
19. Takahashi M, Saito H, Higashimoto M, Atsukawa K, Ishii H. 2005. Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy. J. Clin. Microbiol. 43:186-191. (Pubitemid 40096299)
20. Tedeschi R, et al. 2003. Quantification of hepatitis C virus (HCV) in liver specimens and sera from patients with human immunodeficiency virus coinfection by using the Versant HCV RNA 3.0 (branched DNA-based) DNA assay. J. Clin. Microbiol. 41:3046-3050. (Pubitemid 36842299)
21. Vona G, et al. 2004. Intrahepatic hepatitis C virus RNA quantification in microdissected hepatocytes. J. Hepatol. 40:682-688. (Pubitemid 38367792)
22. White PA, et al. 2002. Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR. J. Clin. Microbiol. 40:4346-4348. (Pubitemid 35285843)